Roche

Healthcare leaders share insights on successfully deploying screening and early disease detection technologies.

Laboratories increasingly face complex pressures potentially impacting results, operating costs, capacity, and turnaround times. By embracing digital solutions to create a more intelligent lab, organizations can be in full control – creating new value and unlocking new possibilities.

This webinar will share how healthcare organizations can enhance their digital infrastructure through best practices and lessons learned. It will address existing barriers to modernization, as well as the programs themselves. Additionally, it will illustrate how such effort can facilitate the scaling of digital technologies to improve screening and early disease detection, with the goal to improve patient outcomes and deliver more efficient, effective care.

How medical algorithms calculate risk to detect chronic disease early.

The current U.S. healthcare system may be strained by a growing workforce shortage, financial constraints and an aging Baby Boomer population, but screening and early disease detection programs offer much-needed support. They can help deliver more efficient and cost-effective treatment plans and better patient outcomes, thereby ensuring sustainability for healthcare providers. 

How a shift to personalised healthcare based on data and evidence can enable sustainable and future-ready healthcare systems in the Asia-Pacific region. 

Mission-based ecosystem collaboration and agile regulation can optimise evidence-based innovation and play an important role in combatting diseases and improving health outcomes.

According to Roche data policy leader Jennifer Pougnet, the case for enabling global data flows as a lever for enhanced patient care, more efficient health systems and advanced research models has never been stronger.

The extent to which the world of digital health has changed during the COVID-19 pandemic has been widely recognised.